Showing 2771-2780 of 3437 results for "".
- Dermatological Society of New Jersey Kicks Off Virtual Conference Saturdayhttps://practicaldermatology.com/news/dermatological-society-of-new-jersey-kicks-off-virtual-conference-saturday/2461147/The DSNJ annual educational conference is a hybrid event this year, with in person as well as online conference experiences open to attendees across the US. The conference is Saturday, April 9. Penn Medicine Princeton Health, accredited by the Medical Society of New Jersey, designa
- Get to Know Allergan Aesthetics’ Allē Flashhttps://practicaldermatology.com/news/get-to-know-allergan-aesthetics-alle-flash/2461135/
- Cetaphil Sensitive Skin Awareness Month Kicks off on March 1, 2022https://practicaldermatology.com/news/cetaphil-sensitive-skin-awareness-month-kicks-off-on-march-1-2022/2461093/Cetaphil is extending Sensitive Skin Awareness Week to a month-long program. Cetaphil is debuting Sensitive Skin Awareness Month this March. In partnership with expert dermatologists and influencers – dubbed the Sensitive Skin Academy – Cetaphil 
- Researchers Define Keys to Recognizing Ocular Rosaceahttps://practicaldermatology.com/news/researchers-define-keys-to-recognizing-ocular-rosacea-1/2461052/A number of eye symptoms may be more common in patients with rosacea compared to those without the skin disease, but the presence of conjunctival telangiectases may be the eye symptom most closely associated with rosacea. Findings come from a study in which researchers evaluated the rig
- Study: Dupixent Improves AD Symptoms in Kids As Young As Six Monthshttps://practicaldermatology.com/news/study-dupixent-improves-ad-symptoms-in-kids-as-young-as-six-months/2460898/Dupixent (dupilumab) significantly reduces signs and symptoms of moderate-to-severe atopic dermatitis in children as young as six months, a new study shows. The trial met its primary and all secondary endpoints, showing that Dupixent added to standard-of-care topical corticosteroids (TC
- MoonLake Immunotherapeutics Taps Former Kymab CEO Simon Sturge as Chairman and Spike Loy for the Board of Directorshttps://practicaldermatology.com/news/moonlake-immunotherapeutics-taps-former-kymab-ceo-simon-sturge-as-chairman-and-spike-loy-for-the-board-of-directors/2460887/Simon Sturge is the new Chairman of MoonLake Immunotherapeutics AG, and Spike Loy has joined the Company’s Board of Directors. Mr. Sturge has 40 years of international leadership experience in the biotechnology and pharmaceutical industry. Most recently, he was Chief Ex
- Vivacare Calls on Derms to Share Knowledge During Psoriasis Awareness Monthhttps://practicaldermatology.com/news/vivacare-calls-on-terms-to-share-knowledge-during-national-psoriasis-month/2460885/Dermatologists from around the country have contributed tips to Vivacare’s education resources and Physician Directory, and the company is inviting others to join in. In honor of Psoriasis Awareness Month, Vivacare is requesting dermatologists share insights regarding psoriasis and its trea
- Lotrimin Taps WWE Superstar and Soles4Souls to Kick Foot Shame to the Curb and Encourage People to #GoWithConfidencehttps://practicaldermatology.com/news/lotrimin-taps-wwe-superstar-and-soles4souls-to-kick-foot-shame-to-the-curb-and-encourage-people-to-gowithconfidence/2460805/Lotrimin is teaming up with WWE Superstar The Miz to educate people on healthy feet habits and help people from all walks of life to #GoWithConfidence through a partnership with Soles4Souls – a nonprofit organization that turns unwanted shoes and clothing into opportunities for people in ne
- Second-Draw PPP Loans: What Dermatologists Should Knowhttps://practicaldermatology.com/news/second-draw-ppp-loans-what-dermatologists-should-know/2460680/By Mark Schmidt, CEO, Fund-Ex Solutions Group Dermatologists have proven their resiliency throughout the pandemic, and now more help is here with another round of funding through the Paycheck Protection Program (PPP). The Economic Aid Act reopened the Small Business Administratio
- NRS Survey Finds Rosacea Patients Lack Knowledge of Antibiotic Resistancehttps://practicaldermatology.com/news/nrs-survey-finds-rosacea-patients-lack-knowledge-of-antibiotic-resistance/2460671/A majority of rosacea patients have never heard of antibiotic resistance, results of a recent survey by the National Rosacea Society (NRS) show. Yet topical or oral antibiotics are among the most commonly prescribed treatments for rosacea. The NRS’s rec